These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 15493169

  • 1. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 2. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 4. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.
    Eur J Gynaecol Oncol; 2004 Oct 09; 25(6):689-98. PubMed ID: 15597844
    [Abstract] [Full Text] [Related]

  • 5. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A.
    Gynecol Oncol; 2000 Nov 09; 79(2):177-80. PubMed ID: 11063640
    [Abstract] [Full Text] [Related]

  • 6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 7. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW, Kelly DP, Rosenthal DL, Ronnett BM.
    Cancer; 2003 Aug 25; 99(4):191-7. PubMed ID: 12925979
    [Abstract] [Full Text] [Related]

  • 8. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM.
    Diagn Cytopathol; 2006 Oct 25; 34(10):707-10. PubMed ID: 16955480
    [Abstract] [Full Text] [Related]

  • 9. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J, Bohbot JM, Pollini G, Krawec C, Vincent C, Merignargues I, Haroun F, Sednaoui P, Monfort L, Dachez R, Syrjänen K.
    Gynecol Oncol; 2005 Oct 25; 99(1):160-8. PubMed ID: 16023184
    [Abstract] [Full Text] [Related]

  • 10. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.
    Int J STD AIDS; 2008 Jun 25; 19(6):385-92. PubMed ID: 18595876
    [Abstract] [Full Text] [Related]

  • 11. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L.
    Acta Cytol; 2000 Jun 25; 44(3):310-8. PubMed ID: 10833984
    [Abstract] [Full Text] [Related]

  • 12. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 25; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S, Austin RM, Dabbs D, Zhao C.
    Arch Pathol Lab Med; 2008 Dec 25; 132(12):1874-81. PubMed ID: 19061283
    [Abstract] [Full Text] [Related]

  • 14. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.
    J Reprod Med; 2001 Sep 25; 46(9):799-805. PubMed ID: 11584480
    [Abstract] [Full Text] [Related]

  • 15. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
    Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK.
    J Low Genit Tract Dis; 2013 Apr 25; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
    [Abstract] [Full Text] [Related]

  • 16. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 25; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 17. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A.
    CMAJ; 2000 Sep 19; 163(6):701-7. PubMed ID: 11022584
    [Abstract] [Full Text] [Related]

  • 18. Primary and Triage Cervical Screening Diagnostic Value of Methods for the Detection of Cervical Dysplasia.
    Njue JK, Muturi M, Kamau L, Lwembe R.
    Biomed Res Int; 2022 Sep 19; 2022():1930102. PubMed ID: 36164451
    [Abstract] [Full Text] [Related]

  • 19. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A, Del Pino M, Molijn A, Rodriguez A, Torné A, de Koning M, Ordi J, van Kemenade F, Jenkins D, Quint W.
    BJOG; 2017 Aug 19; 124(9):1356-1363. PubMed ID: 28391609
    [Abstract] [Full Text] [Related]

  • 20. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.
    Eur J Gynaecol Oncol; 1998 Aug 19; 19(3):203-8. PubMed ID: 9641214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.